Charles Preston, M.D., “a Board Certified Orthopaedic Surgeon and Sports Medicine Specialist with experience in the care of professional athletes and injured patients,” has been elected to the Board of Councilors (BOC) for the American Academy of Orthopaedic Surgeons, representing the Northern California District. “Beginning in March 2020 Dr. Preston’s appointment is effective for a 3-year term with an option for a second 3-year term.”
Charles Preston, M.D. Joins AAOS Board of Councilors

Dr. Preston, who practices at Muir Orthopaedic Specialists in Northern California, is “an orthopedic consultant for local high schools.” He “is certified in both cartilage transplantation and in golf fitness via the Titleist Performance Institute.”
As an elected BOC member, Dr. Preston is also now on the Board of Directors for the California Orthopaedic Association (COA).
Dr. Charles Preston told OTW, “First and foremost, my goal for my first AAOS meeting sitting on the Board of Councilors will be to observe the meeting format, get an idea of the agenda of the organization, and represent Northern California on any actionable agenda items up for input or a vote.”
“My particular advocacy interest is in musculoskeletal injury prevention. I see this area having two main focus groups: First, the young person in their youth and adolescence, and second, the middle age adult making health-related decisions later in life. Young people are particularly vulnerable to injury for a number of reasons, including overuse in sports and participation in high risk sports without appropriate medical personnel available such as an athletic trainer. Older adults become vulnerable as they age and make decisions related to their diet and activity level which can have deleterious effects on their joints. Both areas have room for improvement and prevention programs can address each in benefiting public health as a whole.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.